- Joined
- Mar 31, 2020
- Messages
- 9,153
- Points
- 113
https://www.bloomberg.com/news/articles/202...voids-lab-delay
A 15-minute Covid test from Abbott Laboratories that will be priced at just $5 has been granted emergency authorization for use in the U.S., a breakthrough that could ease the bottleneck that has crimped much of the nation’s testing capacity.
The company’s shares climbed 8.7% to $112.91 at 9:57 a.m. in New York trading. The product, dubbed BinaxNOW, works without relying on laboratory equipment at a time when labs can take as long as two weeks to produce results. It uses a nasal swab and a small reactive card, and it can be administered by a range of health-care workers, including pharmacists, at almost any location.
Abbott will start shipping the test within two weeks and intends to manufacture 50 million tests a month by October. The aim: Meet a surge in demand from Americans seeking to return to in-person schoolrooms and work.
A 15-minute Covid test from Abbott Laboratories that will be priced at just $5 has been granted emergency authorization for use in the U.S., a breakthrough that could ease the bottleneck that has crimped much of the nation’s testing capacity.
The company’s shares climbed 8.7% to $112.91 at 9:57 a.m. in New York trading. The product, dubbed BinaxNOW, works without relying on laboratory equipment at a time when labs can take as long as two weeks to produce results. It uses a nasal swab and a small reactive card, and it can be administered by a range of health-care workers, including pharmacists, at almost any location.
Abbott will start shipping the test within two weeks and intends to manufacture 50 million tests a month by October. The aim: Meet a surge in demand from Americans seeking to return to in-person schoolrooms and work.